Related Experiment Video

Updated: May 21, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

The role of natural killer cells in combinatorial anti-cancer therapy using Sindbis viral vectors and irinotecan

T Granot1, D Meruelo

  • 1Department of Pathology, NYU Cancer Institute, NYU Gene Therapy Center, NYU School of Medicine, New York, USA.

Cancer Gene Therapy
|June 9, 2012
PubMed

Insights

Combining Sindbis viral vector therapy with irinotecan (CPT-11) significantly improves long-term survival in ovarian cancer models. This combination therapy relies on natural killer (NK) cells for its efficacy, offering a new approach to overcoming tumor resistance.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Oncolytic viruses (OVs) show promise in preclinical models but have limited clinical success.
  • Understanding OV mechanisms and interactions with chemotherapy is crucial for clinical application.

Purpose of the Study:

  • To evaluate the efficacy of combining Sindbis viral vector therapy with irinotecan (CPT-11) in ovarian cancer.
  • To elucidate the underlying mechanisms and immune cell involvement in the combinatorial therapy.

Main Methods:

  • Utilized SCID mice bearing aggressive ES2 human ovarian cancer.
  • Administered single-agent treatments (Sindbis or CPT-11) and combinatorial therapy.
  • Employed flow cytometry, bioluminescent imaging, and survival experiments.

Main Results:

  • Combinatorial therapy resulted in long-term survival of ~35% of mice, while single agents did not.
  • Sindbis and CPT-11 exhibited distinct anti-cancer mechanisms: NK-cell-dependent and -independent, respectively.
  • Combinatorial therapy efficacy was dependent on the presence of NK cells.

Conclusions:

  • The combination of Sindbis viral vector and CPT-11 offers a promising strategy for ovarian cancer treatment.
  • NK cell activation plays a critical role in the success of OV-based combinatorial therapies.
  • This approach may overcome tumor resistance and reduce treatment side effects.

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...